Task Profile

Canonical	../StructureDefinition/nexus-emr-core-clinical-task
Status	draft · 1.26.0
Base	Task (constraint)
Source	FSH · JSON

A unit of work in the chart: who asked for it, who owns it now, what has been said about it, and which chart element it concerns. Inbox items, to-dos, follow-ups, a result that needs review -- deliberately one kind of work item.

Examples

Chart-Created · Clinical · Document Review Task, Completed · Clinical task ai triage 001 · Clinical task completed 001 · Clinical task lab review 001 · Clinical task nursing pool 001 · Clinical task referral 001 · Suggested-Resource Task - Add a Chart Entry · Suggested-Resource Task - Card Alternative A (empagliflozin) · Suggested-Resource Task - Card Alternative B (dulaglutide) · Suggested-Resource Task - Retire a Chart Entry · Team-Owned Standalone · Unassigned

Suggested-Resource Task - Card Alternative A (empagliflozin)

One of two mutually exclusive proposals raised by a single decision-support evaluation. Both carry intent = option and the same groupIdentifier under NamingSystem/nexus-cds-card, so the set is recoverable with one group-identifier search; approving either cancels the other, with statusReason recording that it stopped being on offer rather than that anyone declined it

Task/nexus-emr-clinical-task-suggestion-card-a — claims conformance to Task Profile

{
  "resourceType": "Task",
  "id": "nexus-emr-clinical-task-suggestion-card-a",
  "meta": {
    "profile": [
      "../StructureDefinition/nexus-emr-core-clinical-task"
    ],
    "security": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationValue",
        "code": "AIAST",
        "display": "Artificial Intelligence asserted"
      }
    ]
  },
  "contained": [
    {
      "resourceType": "Bundle",
      "id": "suggested",
      "type": "transaction",
      "entry": [
        {
          "fullUrl": "urn:uuid:9f2c8a1e-0000-4000-8000-000000000003",
          "resource": {
            "resourceType": "MedicationRequest",
            "status": "draft",
            "intent": "proposal",
            "medicationCodeableConcept": {
              "coding": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "703894008",
                  "display": "Empagliflozin"
                }
              ],
              "text": "Empagliflozin 10 mg tablet"
            },
            "subject": {
              "reference": "Patient/nexus-emr-patient-attachment-example",
              "display": "Avery Linwood"
            },
            "dosageInstruction": [
              {
                "text": "Take 1 tablet (10 mg) by mouth once daily in the morning"
              }
            ]
          },
          "request": {
            "method": "POST",
            "url": "MedicationRequest"
          }
        }
      ]
    }
  ],
  "identifier": [
    {
      "use": "official",
      "system": "../NamingSystem/nexus-cds-key",
      "value": "dm2-intensification:Patient/avery-linwood-01:empagliflozin"
    }
  ],
  "groupIdentifier": {
    "system": "../NamingSystem/nexus-cds-card",
    "value": "dm2-intensification:Patient/avery-linwood-01:a1c-above-target"
  },
  "status": "ready",
  "intent": "option",
  "priority": "routine",
  "code": {
    "coding": [
      {
        "system": "../CodeSystem/nexus-task-code",
        "code": "medication",
        "display": "Medication"
      }
    ],
    "text": "Suggested medication, one of several alternatives"
  },
  "description": "A1c 8.4% on metformin alone. Suggested add-on: empagliflozin 10 mg daily. ONE OF TWO alternatives offered on the same card -- accepting this one cancels the other.",
  "for": {
    "reference": "Patient/nexus-emr-patient-attachment-example",
    "display": "Avery Linwood"
  },
  "authoredOn": "2026-08-20T07:45:00-04:00",
  "requester": {
    "type": "Device",
    "identifier": {
      "system": "../NamingSystem/nexus-cds-rule",
      "value": "dm2-intensification"
    },
    "display": "Type 2 diabetes intensification rule (decision support)"
  },
  "owner": {
    "reference": "PractitionerRole/dr-ben-mrp-role",
    "display": "Dr. Ben"
  },
  "input": [
    {
      "type": {
        "coding": [
          {
            "system": "../CodeSystem/nexus-task-input-type",
            "code": "suggested-resource",
            "display": "Suggested resource"
          }
        ]
      },
      "valueReference": {
        "reference": "#suggested",
        "display": "Suggested resource Bundle"
      }
    }
  ],
  "note": [
    {
      "authorReference": {
        "identifier": {
          "system": "../NamingSystem/nexus-cds-rule",
          "value": "dm2-intensification"
        },
        "display": "Type 2 diabetes intensification rule (decision support)"
      },
      "time": "2026-08-20T07:45:00-04:00",
      "text": "Last A1c 8.4% on metformin monotherapy, above the agreed target. This is one of two alternatives offered together; accepting either closes the other."
    }
  ]
}